Literature DB >> 17992708

Social costs of robbery and the cost-effectiveness of substance abuse treatment.

Anirban Basu1, A David Paltiel, Harold A Pollack.   

Abstract

Reduced crime provides a key benefit associated with substance abuse treatment (SAT). Armed robbery is an especially costly and frequent crime committed by some drug-involved offenders. Many studies employ valuation methods that understate the true costs of robbery, and thus the true social benefits of SAT-related robbery reduction. At the same time, regression to the mean and self-report bias may lead pre-post comparisons to overstate crime reductions associated with SAT. Using 1992-1997 data from the National Treatment Improvement Evaluation Study (NTIES), we examined pre-post differences in self-reported robbery among clients in five residential and outpatient SAT modalities. Fixed-effect negative binomial regression was used to examine incidence rate reductions (IRR) in armed robbery. Published data on willingness to pay to avoid robbery were used to determine the social valuation of these effects. Differences in IRR across SAT modalities were explored to bound potential biases.All SAT modalities were associated with large and statistically significant reductions in robbery. The average number of self-reported robberies declined from 0.83/client/year pre-entry to 0.12/client/year following SAT (p<0.001). Under worst-case assumptions, monetized valuations of reductions in armed robbery associated with outpatient methadone and residential SAT exceeded economic costs of these interventions. Conventional wisdom posits the economic benefits of SAT. We find that SAT is even more beneficial than is commonly assumed. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2008        PMID: 17992708      PMCID: PMC3512566          DOI: 10.1002/hec.1305

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  28 in total

Review 1.  Nonresponse and selection bias in treatment follow-up studies.

Authors:  D R Gerstein; R A Johnson
Journal:  Subst Use Misuse       Date:  2000 May-Jun       Impact factor: 2.164

2.  Cost-benefit and cost-effectiveness analysis of drug abuse treatment services.

Authors:  W S Cartwright
Journal:  Eval Rev       Date:  1998-10

3.  Characterizing criminal careers.

Authors:  A Blumstein; J Cohen
Journal:  Science       Date:  1987-08-28       Impact factor: 47.728

4.  The impact of needle exchange-based health services on emergency department use.

Authors:  Harold A Pollack; Kaveh Khoshnood; Kim M Blankenship; Frederick L Altice
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

5.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

Review 6.  The cost-effectiveness of methadone maintenance as a health care intervention.

Authors:  P G Barnett
Journal:  Addiction       Date:  1999-04       Impact factor: 6.526

7.  Cost-benefit analysis of drug treatment services: review of the literature*

Authors:  William S. Cartwright
Journal:  J Ment Health Policy Econ       Date:  2000-03-01

8.  The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment.

Authors:  Gary A Zarkin; Laura J Dunlap; Jeremy W Bray; Wendee M Wechsberg
Journal:  J Subst Abuse Treat       Date:  2002-12

9.  Ownership and performance of outpatient substance abuse treatment centers.

Authors:  J R Wheeler; H Fadel; T A D'Aunno
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

10.  Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.

Authors:  Ramin Mojtabai; Joshua Graff Zivin
Journal:  Health Serv Res       Date:  2003-02       Impact factor: 3.402

View more
  10 in total

1.  The costs of crime associated with stimulant use in a Canadian setting.

Authors:  Benjamin Enns; Emanuel Krebs; Kora DeBeck; Kanna Hayashi; M-J Milloy; Lindsey Richardson; Evan Wood; Bohdan Nosyk
Journal:  Drug Alcohol Depend       Date:  2017-09-14       Impact factor: 4.492

2.  Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care.

Authors:  Anirban Basu
Journal:  J Health Econ       Date:  2011-04-23       Impact factor: 3.883

3.  So Prescription Opioid Disorders are a $78.5 Billion Problem.

Authors:  Harold A Pollack
Journal:  Med Care       Date:  2016-10       Impact factor: 2.983

4.  The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients.

Authors:  Todd A Olmstead; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2009-03-25       Impact factor: 4.492

5.  The cost-effectiveness of Vancouver's supervised injection facility.

Authors:  Ahmed M Bayoumi; Gregory S Zaric
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

Review 6.  Economic Evaluations of Opioid Use Disorder Interventions.

Authors:  Sean M Murphy; Daniel Polsky
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981

Review 7.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

8.  Cost-effectiveness of peer-delivered interventions for cocaine and alcohol abuse among women: a randomized controlled trial.

Authors:  Jennifer Prah Ruger; Jennifer Prah Ruger; Arbi Ben Abdallah; Craig Luekens; Linda Cottler
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

9.  Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.

Authors:  Jennifer Prah Ruger; Marek Chawarski; Mahmud Mazlan; Nora Ng; Richard Schottenfeld
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

10.  Directed funding to address under-provision of treatment for substance use disorders: a quantitative study.

Authors:  Austin B Frakt; Jodie Trafton; Amy Wallace; Matthew Neuman; Steven Pizer
Journal:  Implement Sci       Date:  2013-07-18       Impact factor: 7.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.